Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px
Document › Details

bioMérieux S.A.. (2/28/18). "Press Release: 2017 Financial Results".

Organisations Organisation bioMérieux S.A. (Euronext: BIM)
  Group Mérieux (Group)
  Organisation 2 Banyan Biomarkers Inc.
Products Product in vitro diagnostics (IVD)
  Product 2 molecular diagnostics
Index term Index term Qvella–Mérieux: investment, 201712 financing round Series B totallling $20m incl co-lead + new strategic investor bioMérieux
Person Person Mérieux, Alexandre (Mérieux 201712– CEO at bioMérieux before Deputy CEO before VP Industrial Microbiology)
     


>Excellent sales momentum in 2017 with a 10.2% increase in sales, at constant exchange rates and scope of consolidation:
–– €2,288 million in sales
–– Up 8.8% as reported

> Strong 12.4% increase in contributive operating income before non-recurring items to €335 million, in line with the objectives set

> Fast growth in free cash flow to €164 million versus €85 million in 2016

> 2018 objectives:
–– Organic growth in sales of between 8% and 9%, at constant exchange rates and scope of consolidation
–– Contributive operating income before non-recurring items of between €325 million and €345 million, despite a negative currency impact anticipated at around €40 million


Alexandre Mérieux, Chairman and Chief Executive Officer, said: “bioMérieux delivered another solid operating and financial performance in 2017. Thanks to a robust sales momentum and careful control of operating expenses, the Company recorded sharp increases in contributive operating income before non-recurring items, net income and free cash flow. Buoyed by these results, we head into 2018 with the ambition to sustain this dynamic while strengthening our commitment to innovation and R&D.”

Download [Full release at http://www.biomerieux.com/sites/corporate/files/news-event-press-release/biomerieux_pr_2017_results.pdf ]

   
Record changed: 2018-03-27

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px

More documents for Mérieux (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px




» top